Book Summary
The Gene is Siddhartha Mukherjee’s history of the most powerful idea in biology, told as a braid of three threads: the science, from Mendel’s pea plants to CRISPR; the human cost, from eugenics to the asylum; and his own family’s haunting by mental illness, with schizophrenia and bipolar disorder recurring across generations. The question driving all three threads is deceptively simple: what does it mean to say a trait is inherited?
The scientific thread runs from Gregor Mendel’s monastery garden through Darwin’s failed theory of pangenesis, the rediscovery of Mendel in 1900, Thomas Hunt Morgan’s fly room at Columbia, and the double helix, with Mukherjee giving Rosalind Franklin her overdue due. It continues through the Human Genome Project, the race between the public consortium and Craig Venter’s Celera, and the strange anticlimax when the genome turned out to contain only about twenty thousand genes, far fewer than expected, launching the hunt for what regulates them.
The human thread is darker. Mukherjee does not flinch from eugenics: Francis Galton’s coinage of the term, the American sterilization laws upheld in Buck v. Bell, with Oliver Wendell Holmes’s infamous line about three generations of imbeciles being enough, and the Nazi regime’s murderous appropriation of the idea. The point is not to condemn genetics but to show what happens when a half-understood science meets the human urge to improve the stock: catastrophe, delivered with the confidence of experts.
The final thread is the post-genomic present: genome-wide association studies, the puzzle of missing heritability, epigenetics, gene therapy’s first cures and first disasters, and CRISPR’s arrival as a technology that can rewrite the code itself. Mukherjee closes not with answers but with the questions the science forces on us: what counts as normal, who gets to decide, and what we owe the unborn once we can edit them.
Who is Siddhartha Mukherjee?
Siddhartha Mukherjee is a physician, oncologist, and researcher at Columbia University, known for writing science with the narrative command of a novelist. He won the Pulitzer Prize for The Emperor of All Maladies, his biography of cancer, and followed it with The Laws of Medicine and The Song of the Cell. The Gene is his biography of heredity itself, and it carries the same signature move: big science rendered through individual human stories.
What distinguishes Mukherjee is that he writes from inside both worlds. He is a practicing doctor who has delivered genetic diagnoses to families, and a researcher who understands the molecular machinery. When he describes his own dread that his family’s mental illness might be written into his children’s genomes, it is not a literary device. It is the reason the book exists.
Lessons From The Gene
The deepest lesson is the difference between heritability and determinism. That a trait is substantially heritable does not mean it is fixed; height is highly heritable and has risen dramatically with nutrition. Mukherjee hammers this distinction because so much mischief, from eugenics to genetic fatalism, comes from collapsing it. For investors, the parallel is base rates versus destiny: a strong historical pattern constrains the future without scripting it, and confusing the two is how you get both bad science and bad position sizing.
The second lesson is about complexity. The genome project expected a parts list and found an operating system: most traits are polygenic, built from thousands of variants of tiny effect, interacting with environment in ways we barely understand. The era of one gene, one trait, one cure is over, if it ever existed. This is a useful humility template for anyone who models complex systems, markets included: beware the analyst selling you the single gene, the single factor, the single cause.
The third lesson is the eugenics warning, and it generalizes. Every powerful technology for reading or editing human nature will be captured, at first, by whoever is most confident about what counts as improvement. The early geneticists were not cranks; they were the scientific establishment, certain they were doing good. The Gene is, among other things, a 500-page argument for epistemic humility: the people most sure they understand the system are the most dangerous people to hand the controls to.
The fourth lesson is about what counts as normal. As sequencing gets cheaper, each of us turns out to carry dozens of potentially damaging variants, and the line between normal variation and pathology dissolves into statistics. Mukherjee suggests the post-genomic self will have to live with probabilistic knowledge about its own future, acting on risks rather than certainties. Anyone who has managed a portfolio under uncertainty will recognize the discipline: you do not get to wait for certainty, you size the bet to the odds.
Criticisms of the Book
The book is sprawling, and the family-memoir thread occasionally strains under the weight it is asked to carry. Mukherjee returns to his relatives’ mental illness as a framing device so often that some passages feel engineered for symmetry rather than discovered in the material. The science writing is superb; the memoir writing is good, and the seams occasionally show.
The technical depth is also uneven. Readers with real biology background will find the molecular chapters simplified to the point of smoothing over genuine controversies, particularly around epigenetics, where Mukherjee is more enthusiastic than the evidence warrants. And the CRISPR chapters, written before the technology’s clinical era and before the He Jiankui scandal, now read as a dispatch from an earlier, more innocent moment.
Finally, the eugenics history, while well told, covers familiar ground for readers of the history of science. Mukherjee’s treatment is humane and unsparing, but it breaks little new historiographical ground. None of this sinks the book; it is the difference between a great book and a perfect one.
Who is This Book For?
This is a book for the scientifically curious general reader, for parents weighing genetic testing, and for anyone who wants to understand what the biotech century will actually argue about. Investors in healthcare and biotech will find it especially useful: The Gene is the fastest way to develop informed skepticism about gene-therapy press releases and polygenic-score startups.
It is not a textbook and will not teach you to read a GWAS paper. What it teaches is judgment: how to think about heredity without falling into either genetic determinism or blank-slate denial. In a decade when DNA testing is a consumer product, that judgment is close to a survival skill.
Final Thoughts
The Gene does for heredity what The Emperor of All Maladies did for cancer: it takes a technical subject of enormous human consequence and makes it feel like the most important story in the world, because it is. Mukherjee’s great gift is making you feel the weight of an idea across centuries, from a monk counting peas to a lab editing embryos.
Read it for the science, stay for the questions. Long after the details of transcription factors fade, you will still be turning over the central one: now that we can read the code, and soon rewrite it, what kind of creatures do we want to be? No investing book will ask you that. This one will not let you dodge it.
